Model Systems: transgenic mouse models for measles pathogenesis

M Manchester1, G F Rall

  • 1Dept of Neuropharmacology (IMM6), The Scripps Research Institute, La Jolla, CA 92037, USA. marim@scripps.edu

Trends in Microbiology
|February 13, 2001
PubMed

Insights

Developing measles virus (MV) susceptible transgenic mice offers a vital animal model for studying human MV diseases. These models aid in understanding immune responses and developing new antiviral therapies and vaccines.

Area of Science:

  • Virology
  • Immunology
  • Transgenic animal models

Background:

  • Studying measles virus (MV) in humans is challenging due to the absence of adequate animal models.
  • Measles virus causes significant human diseases, including neurological complications and immunosuppression.

Purpose of the Study:

  • To develop and characterize a transgenic mouse model susceptible to measles virus infection.
  • To utilize this model for investigating MV pathogenesis and immune responses.

Main Methods:

  • Leveraged the discovery of cellular receptors for MV entry.
  • Created transgenic mice engineered for susceptibility to MV infection.

Main Results:

  • Transgenic mice exhibit susceptibility to MV infection.
  • These mice replicate key aspects of human MV central nervous system diseases and immunosuppression.
  • The model facilitates studying innate and adaptive immune responses to MV.

Conclusions:

  • Transgenic mice susceptible to MV provide a valuable preclinical model.
  • This model is crucial for advancing the understanding of MV disease mechanisms.
  • It will accelerate the development of novel antiviral drugs and vaccines against measles.